GRIFOLS S.A. - stock earnings
GRF.MC Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | 59.5 million EUR | 1.6 billion EUR |
| 2023Q2 | 60.0 million EUR | 1.7 billion EUR |
| 2023Q1 | -108.3 million EUR | 1.6 billion EUR |
| 2022Q4 | 20.1 million EUR | 1.7 billion EUR |
| 2022Q3 | 44.6 million EUR | 1.5 billion EUR |
| 2022Q2 | 90.3 million EUR | 1.5 billion EUR |
| 2022Q1 | 53.3 million EUR | 1.3 billion EUR |
| 2021Q4 | -42.0 million EUR | 1.2 billion EUR |
| 2021Q3 | -42.0 million EUR | 1.2 billion EUR |
| 2021Q2 | 136.9 million EUR | 1.4 billion EUR |
| 2021Q1 | 129.9 million EUR | 1.2 billion EUR |
| 2020Q4 | 132.9 million EUR | 1.3 billion EUR |
| 2020Q3 | 267.4 million EUR | 1.4 billion EUR |
| 2020Q2 | 31.9 million EUR | 1.4 billion EUR |
| 2020Q1 | 186.4 million EUR | 1.3 billion EUR |
| 2019Q4 | 201.7 million EUR | 1.4 billion EUR |
| 2019Q3 | 136.5 million EUR | 1.3 billion EUR |
| 2019Q2 | 172.5 million EUR | 1.3 billion EUR |
| 2019Q1 | 114.4 million EUR | 1.2 billion EUR |
| 2018Q4 | 128.3 million EUR | 1.2 billion EUR |
| 2018Q3 | 149.3 million EUR | 1.1 billion EUR |
| 2018Q2 | 175.6 million EUR | 1.1 billion EUR |
| 2018Q1 | 143.4 million EUR | 1.0 billion EUR |
| 2017Q4 | 230.9 million EUR | 1.1 billion EUR |
| 2017Q3 | 153.9 million EUR | 1.1 billion EUR |
| 2017Q2 | 143.9 million EUR | 1.1 billion EUR |
| 2017Q1 | 134.0 million EUR | 1.1 billion EUR |
| 2016Q4 | 139.4 million EUR | 1.1 billion EUR |
| 2016Q3 | 141.7 million EUR | 1.0 billion EUR |
| 2016Q2 | 139.2 million EUR | 992.7 million EUR |
| 2016Q1 | 125.2 million EUR | 958.9 million EUR |
| 2015Q4 | 130.5 million EUR | 1.1 billion EUR |
| 2015Q3 | 140.1 million EUR | 971.2 million EUR |
| 2015Q2 | 133.0 million EUR | 992.2 million EUR |
| 2015Q1 | 128.5 million EUR | 908.4 million EUR |
| 2014Q4 | 131.3 million EUR | 917.3 million EUR |
| 2014Q3 | 114.2 million EUR | 827.3 million EUR |
| 2014Q2 | 103.9 million EUR | 812.8 million EUR |
| 2014Q1 | 121.0 million EUR | 798.0 million EUR |
| 2013Q4 | 78.5 million EUR | 695.2 million EUR |
| 2013Q3 | 84.2 million EUR | 665.7 million EUR |
| 2013Q2 | 91.8 million EUR | 697.1 million EUR |
| 2013Q1 | 91.0 million EUR | 683.7 million EUR |
| 2012Q4 | 59.3 million EUR | 661.4 million EUR |
| 2012Q3 | 63.8 million EUR | 642.8 million EUR |
| 2012Q2 | 66.0 million EUR | 650.0 million EUR |
| 2012Q1 | 67.5 million EUR | 666.7 million EUR |
| 2011Q4 | 6.5 million EUR | 590.1 million EUR |
| 2011Q3 | 24.5 million EUR | 570.2 million EUR |
| 2011Q2 | -14.4 million EUR | 373.9 million EUR |
| 2011Q1 | 33.6 million EUR | 261.4 million EUR |
| 2010Q4 | 18.5 million EUR | 251.9 million EUR |
| 2010Q3 | 30.6 million EUR | 193.1 million EUR |
GRF.MC Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 23.4 million EUR | 6.5 billion EUR |
| 2022 | 208.3 million EUR | 6.1 billion EUR |
| 2021 | 265.3 million EUR | 4.9 billion EUR |
| 2020 | 618.5 million EUR | 5.3 billion EUR |
| 2019 | 625.1 million EUR | 5.1 billion EUR |
| 2018 | 596.6 million EUR | 4.5 billion EUR |
| 2017 | 662.7 million EUR | 4.3 billion EUR |
| 2016 | 545.5 million EUR | 4.0 billion EUR |
| 2015 | 532.1 million EUR | 3.9 billion EUR |
| 2014 | 470.3 million EUR | 3.4 billion EUR |
| 2013 | 345.6 million EUR | 2.7 billion EUR |
| 2012 | 256.7 million EUR | 2.6 billion EUR |
| 2011 | 50.3 million EUR | 1.8 billion EUR |
| 2010 | 115.5 million EUR | 990.7 million EUR |
| 2009 | 148.0 million EUR | 913.2 million EUR |
| 2008 | 121.7 million EUR | 814.3 million EUR |
| 2007 | 87.8 million EUR | 703.3 million EUR |
| 2006 | 45.4 million EUR | 648.8 million EUR |
| 2005 | 25.6 million EUR | 524.3 million EUR |
GRF.MC
Price: €8.65
52 week price:
Earnings Per Share: 0.09 EUR
P/E Ratio: 267.25
Exchange: MCE
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 1.1 million
Market Capitalization: 5.3 billion
Average Dividend Frequency: 2